Tags : IBI305

Innovent Biosciences Collaborates with Chipscreen to Evaluate Chidamide in Combination

Shots: The companies collaborated to jointly assess safety and efficacy of Chipscreen’s Chidamide in combination with Innovent’s Sintilimab + IBI305 in patients with advanced colorectal carcinoma (ACC) The focus of the agreement is to explore the combination in clinical applications of immune check-point inhibitor, angiogenesis inhibitor and epigenetic modulator in ACC  Chidamide is a HDAC […]Read More